Resistance to chemotherapeutics involves complex mechanisms that can result from dysregulated signaling, enhanced DNA repair, altered cancer cell metabolism [3,4], drug transport and metabolism [5], and the dysregulation of survival factors, including FLIP, Xiap and Akt [6-9]. Here, AKT1 is linked to cancer.